Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up

Fertility and Sterility

Volumn 78, Issue 5, 2002, Pages 1025-1029

  Kolibianakis, Efstratios ^a   Bourgain, Claire ^a   Albano, Carola ^a   Osmanagaoglu, Kaan ^a   Smitz, Johan ^a   Van Steirteghem, Andre ^a   Devroey, Paul ^a  

^a CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

Author keywords

Endometrial biopsy; GnRH antagonists; hCG; Ovarian stimulation; Recombinant FSH

Indexed keywords

CHORIONIC GONADOTROPIN; GANIRELIX; GONADORELIN ANTAGONIST; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; ASPIRATION BIOPSY; CONTROLLED STUDY; DRUG EFFECT; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEMALE; FERTILIZATION IN VITRO; HISTOLOGY; HUMAN; HUMAN TISSUE; INTRACYTOPLASMIC SPERM INJECTION; MAJOR CLINICAL STUDY; MATURATION; OOCYTE; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PRIORITY JOURNAL;

ADULT; BIOPSY; CHORIONIC GONADOTROPIN; ENDOMETRIUM; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; OOCYTES; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; SPERM INJECTIONS, INTRACYTOPLASMIC; TISSUE AND ORGAN HARVESTING;

EID: 0036843858     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0015-0282(02)03323-X     Document Type: Article

References (18)

1. Borm G., Mannaerts B. Treatment with the gonadotropin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. The European Orgalutran Study Group. Hum Reprod. 7:2000;1490-1498.
2. Fluker M., Grifo J., Leader A., Levy M., Meldrum D., Muasher S.J., et al. Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril. 1:2001;38-45.
3. Olivennes F., Belaisch-Allart J., Emperaire J.C., Dechaud H., Alvarez S., Moreau L., et al. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). Fertil Steril. 2:2000;314-320.
4. Albano C., Felberbaum R.E., Smitz J., Riethmuller-Winzen H., Engel J., Diedrich K., et al. Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. Hum Reprod. 3:2000;526-531.
5. The European Middle East Orgalutran Study Group . Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod. 16:2001;644-651.
6. Al-Inany H., Aboulghar M. Gonadotropin-releasing hormone antagonists for assisted conception. The Cochrane Database of Systematic Reviews 2001. Volume (Issue 4):2001.
7. Kol S., Lightman A., Hillensjo T., Devroey P., Fauser B., Tarlatzis B., et al. High doses of gonadotropin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles. Hum Reprod. 9:1999;2242-2244.
8. Kol S. Embryo implantation and GnRH antagonists GnRH antagonists in ART lower embryo implantation? Hum Reprod. 9:2000;1881-1882.
9. Diedrich K., Frydman R., Devroey P., Felberbaum R., Schally A.V., Reissmann T., et al. Comment on the debate article: embryo implantation: the Rubicon for GnRH antagonists. Hum Reprod. 6:2001;1305-1306.
10. Mannaerts B., Gordon K. Embryo implantation and GnRH antagonists GnRH antagonists do not activate the GnRH receptor . Hum Reprod. 9:2000;1882-1883.
11. Van Steirteghem A.C., Nagy Z., Joris H., Liu J., Staessen C., Smitz J., et al. High fertilization and implantation rates after intracytoplasmic sperm injection. Hum Reprod. 7:1993;1061-1066.
12. Devroey P., Tjandraprawira K., Mannaerts B., Coelingh Bennink H., Smitz J., Bonduelle M., et al. A randomized, assessor-blind, group-comparative efficacy study to compare the effects of Normegon and Metrodin in infertile female patients undergoing in-vitro fertilization. Hum Reprod. 2:1995;332-337.
13. Ubaldi F., Bourgain C., Tournaye H., Smitz J., Van Steirteghem A., Devroey P. Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase. Fertil Steril. 67:1997;521-526.
14. Chetkowski R.J., Kiltz R.J., Salyer W.R. In premature luteinization, progesterone induces secretory transformation of the endometrium without impairment of embryo viability. Fertil Steril. 2:1997;292-297.
15. Garcia J.E., Acosta A.A., Hsiu J.G., Jones H.W. Advanced endometrial maturation after ovulation induction with human menopausal gonadotropin/human chorionic gonadotropin for in vitro fertilization. Fertil Steril. 1:1984;31-35.
16. Marchini M., Fedele L., Bianchi S., Losa G.A., Ghisletta M., Candiani G.B. Secretory changes in preovulatory endometrium during controlled ovarian hyperstimulation with buserelin acetate and human gonadotropins. Fertil Steril. 4:1991;717-721.
17. de Ziegler D. Hormonal control of endometrial receptivity. Hum Reprod. 1:1995;4-7.
18. Bouchard P., Marraoui J., Massai M.R., Medalie D.A., De Ziegler D., Perrot-Applanat M., et al. Immunocytochemical localization of estradiol and progesterone receptors in human endometrium a tool to assess endometrial maturation . Baillieres Clin Obstet Gynaecol. 1:1991;107-115.